• National Cancer Institute
  • National Human Genome Research Institute

TCGA In The NewsRSS

The Cancer Genome Atlas (TCGA) Research Network is providing data and genome analysis to the cancer research community which is supporting new discoveries and accelerating the pace of cancer research. Below is a list of selected articles that describe the broad impact of TCGA on cancer research.


  • September 24, 2012
    Video: First Comprehensive Genetic Analysis of Breast Cancer Could Change Treatment (07:36)
    PBS's Judy Woodruff interviews Dr. Harold Varmus, the director of the National Cancer Institute, regarding The Cancer Genome Atlas's comprehensive breast cancer study and its possible future implications.
  • September 24, 2012
    Scientists Parse Genes Of Breast Cancer's Four Major Types
    NPR's Richard Knox reports on The Cancer Genome Atlas's findings from their latest comprehensive breast cancer study.
  • September 23, 2012
    Study Divides Breast Cancer Into Four Distinct Types
    The New York Times reports on the The Cancer Genome Atlas Research Network's comprehensive genomic characterization of breast cancer, and their study of the four major genomic subtypes of the disease.
  • September 09, 2012
    Cancer Study Points to Tighter Pairing of Drugs and Patients
    The New York Times reports on the findings of The Cancer Genome Atlas Research Network's comprehensive genomic characterization of lung squamous cell carcinoma and possible potential treatment from drugs in the FDA pipeline.
  • July 18, 2012
    Genetic Aberrations Seen as Path to Stop Colon Cancer
    The New York Times reports on the findings and implications of The Cancer Genome Atlas Research Network's comprehensive genomic characterization of colorectal cancer.
  • March 02, 2012
    Combing the Cancer Genome
    The Scientist gives a guided tour through the main online resources for analyzing data from The Cancer Genome Atlas. The article discusses tools available within the TCGA Data Portal, and outside it.
  • December 23, 2011
    TCGA Considered a "Notable Advance"
    The Cancer Genome Atlas is considered a "Notable Advance" according to a report compiled by 18 prominent oncologists, covering the period from October 2010 to September 2011. "Notable Advances" are research that has had a significant impact on the way a cancer is understood or has had a direct impact on patient care.
  • August 16, 2011
    TCGA Ranks in Top Five of Most Highly Ranked Articles
    In this snapshot of the most highly ranked articles in molecular biology, The Cancer Genome Atlas Research Network's article “Integrated genomic analyses of ovarian carcinoma”, published in Nature, is number five.
  • August 04, 2011
    Analyzing the Genetic Makeup of Ovarian Cancer
    Dr. Douglas Levine, a physician and researcher at Memorial Sloan-Kettering Cancer Center, discusses the impact of understanding cancer genetics as it relates to a patient's care.
  • November 30, 2010
    Audio: Researchers Discover Key Mutation in Acute Myeloid Leukemia
    Tim Ley, M.D., Washington University researcher, discusses the importance of a key mutation found in acute myeloid leukemia. This mutation may be an important tool to classify patients for treatment.
1 2 3 Next >